Federal Circuit Rules For Competitive Technologies In Patent Suit Vs. LabCorp

Law360 (June 8, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has affirmed a lower court’s decision that Laboratory Corporation of America Holdings willfully contributed to and induced infringement of Competitive Technologies’s patent for a technology used in diagnoses of heart conditions.

In November 2002, Senior Judge Zita L. Weinshienk of the U.S. District Court for the District of Colorado ruled that LabCorp willfully contributed to and induced infringement of CTT's so-called homocysteine assay patent.

CTT, along with Metabolite Laboratories, sued LabCorp in May 1999. The complaint alleged,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.